Humana Inc (HUM) Holdings Increased by Meadow Creek Investment Management LLC

Meadow Creek Investment Management LLC boosted its stake in shares of Humana Inc (NYSE:HUM) by 40.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 79,310 shares of the insurance provider’s stock after purchasing an additional 22,880 shares during the quarter. Meadow Creek Investment Management LLC’s holdings in Humana were worth $19,674,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HUM. Fieldpoint Private Securities LLC acquired a new stake in Humana during the 3rd quarter worth about $115,000. American Beacon Advisors Inc. acquired a new stake in Humana during the 4th quarter worth about $122,000. ClariVest Asset Management LLC acquired a new stake in Humana during the 3rd quarter worth about $144,000. YorkBridge Wealth Partners LLC increased its holdings in shares of Humana by 99.0% in the 4th quarter. YorkBridge Wealth Partners LLC now owns 597 shares of the insurance provider’s stock valued at $159,000 after purchasing an additional 297 shares during the period. Finally, Daiwa SB Investments Ltd. increased its holdings in shares of Humana by 44.9% in the 4th quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after purchasing an additional 220 shares during the period. Hedge funds and other institutional investors own 97.85% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other Humana news, SVP Cynthia H. Zipperle sold 1,196 shares of the company’s stock in a transaction that occurred on Friday, March 9th. The stock was sold at an average price of $273.33, for a total transaction of $326,902.68. Following the completion of the sale, the senior vice president now owns 7,771 shares of the company’s stock, valued at $2,124,047.43. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Timothy S. Huval sold 1,382 shares of the company’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the sale, the vice president now directly owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. Insiders have sold 41,775 shares of company stock valued at $11,169,845 in the last ninety days. Company insiders own 0.60% of the company’s stock.

A number of equities analysts have recently weighed in on the company. Deutsche Bank upped their target price on Humana from $259.00 to $270.00 and gave the company a “hold” rating in a report on Friday, February 9th. Cantor Fitzgerald reiterated a “hold” rating and issued a $250.00 target price on shares of Humana in a report on Wednesday, February 7th. Credit Suisse Group upgraded Humana from a “neutral” rating to an “outperform” rating and dropped their target price for the company from $264.90 to $246.00 in a report on Thursday, February 8th. Goldman Sachs Group assumed coverage on Humana in a report on Wednesday, January 3rd. They issued a “buy” rating and a $305.00 target price on the stock. Finally, JPMorgan Chase & Co. upped their target price on Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a report on Monday, February 12th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $270.47.

Shares of Humana Inc (NYSE:HUM) opened at $268.21 on Tuesday. The company has a market capitalization of $37,518.98, a P/E ratio of 16.08, a P/E/G ratio of 1.48 and a beta of 0.95. Humana Inc has a 12 month low of $203.48 and a 12 month high of $293.35. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.48.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.06. The business had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a return on equity of 16.13% and a net margin of 4.55%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.34 EPS. research analysts expect that Humana Inc will post 13.81 earnings per share for the current year.

Humana declared that its Board of Directors has approved a share repurchase program on Thursday, December 14th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the insurance provider to repurchase shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

The company also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, March 30th will be paid a $0.50 dividend. This is a boost from Humana’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $2.00 annualized dividend and a dividend yield of 0.75%. Humana’s payout ratio is presently 9.59%.

ILLEGAL ACTIVITY WARNING: “Humana Inc (HUM) Holdings Increased by Meadow Creek Investment Management LLC” was originally reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.themarketsdaily.com/2018/03/13/humana-inc-hum-holdings-increased-by-meadow-creek-investment-management-llc.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply